ABT · News · 20260812N
Revenue Performance and Mix
ABBOTT LABORATORIES · 2026-08-12 · Importance 43 · Surprise 22 · In source text
Abbott reported quarterly revenue of $12.59 billion, up 13% year over year. The revenue result exceeded analyst expectations for the quarter. Adjusted EPS was $1.31, also above consensus estimates.
Key facts
- Quarterly revenue: $12.59 billion. source
- Revenue up 13% year-over-year. source
- Adjusted EPS for the quarter: $1.31. source
- Shares of Abbott Laboratories rose 1.08% to $110.91, marking its third consecutive day of gains. source
- Consensus rating from twenty-six brokerages: "Moderate Buy" with an average 12-month price target of $118.17. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | Quarterly revenue: $12.59 billion. |